INTERNATIONAL PATENT: GILEAD SCIENCES, INC. FILES APPLICATION FOR "(R)-5-FLUORO-2-METHYL-1-((R)-5-(PYRIDIN-2-YL)-2,3-DIHYDRO-1 H-INDENE-2-CARBONYL)INDOLINE-6-SULFONAMIDE FOR TREATMENT OF VIRAL INFECTIONS UNRESPONSIVE TO TREATMENT WITH A FIRST ANTIVIRAL THERAPY"

GENEVA, Jan. 20 -- GILEAD SCIENCES, INC. (333 Lakeside DriveFoster City, California 94404) filed a patent application (PCT/US2025/037209) for "(R)-5-FLUORO-2-METHYL-1-((R)-5-(PYRIDIN-2-YL)-2,3-DIHYDRO-1 H-INDENE-2-CARBONYL)INDOLINE-6-SULFONAMIDE FOR TREATMENT OF VIRAL INFECTIONS UNRESPONSIVE TO TREATMENT WITH A FIRST ANTIVIRAL THERAPY" on Jul 10, 2025. With publication no. WO/2026/015762, the details related to the patent application was published on Jan 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MERCIER, Alexandre (c/o Gilead Sciences, Inc.333 Lakeside DriveFoster City, California ...